Yanelys Morera-Díaz

4PUBLICATIONS
8CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 27, 2026
Longitudinal Assessment of an 800 µg Dose of HEBERSaVax in Non-Human Primates over Six Months.

Camila Canaán-Haden, Isabel Gonzalez-Moya, Monica Bequet-Romero

|Oct 16, 2025
HEBERSaVax immunotherapy combined with first-line chemotherapy in advanced ovarian cancer: Phase II CENTAURO-4 trial results.

Francisco Hernández-Bernal, Katty-Hind Selman-Housein Bernal, Monica Bequet-Romero

|Apr 23, 2025
Immunogenicity and Safety Profile of Two Adjuvanted-PD-L1-Based Vaccine Candidates in Mice, Rats, Rabbits, and Cynomolgus Monkeys.

Camila Canaán-Haden, Javier Sánchez-Ramírez, Rafael Martínez-Castillo

|Apr 04, 2022
Potential mechanisms involved on how systemic IgG antibodies specific to vascular endothelial growth factor (VEGF) and induced by active immunotherapy decrease platelet derived free-VEGF.

Javier Sánchez Ramírez, Yanelys Morera Díaz, Mónica Bequet-Romero

Pageof 1

Frequent Collaborators

3 joint publications

Mónica Bequet-Romero

2 joint publications

Camila Canaán-Haden

2 joint publications

Isabel Gonzalez-Moya

2 joint publications

Alexei F Licea-Navarro